Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.
Main Authors: | Seeman, A, McClung, M, Zippel, H, Bensen, W, Cooper, C, Benhamou, C, DiGennaro, J, Zorich, N, Reginster, J |
---|---|
Format: | Journal article |
Published: |
2000
|
Similar Items
-
Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
by: Cooper, C, et al.
Published: (2001) -
Romosozumab for the treatment of osteoporosis
by: Michael R. McClung
Published: (2018-03-01) -
Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.
by: Sorensen, O, et al.
Published: (2003) -
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
by: Watts, N, et al.
Published: (2004) -
Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation
by: Boyanov M, et al.
Published: (2012-04-01)